ERBB2 and neoplasm: In fact, EGFR-IR700 was shown to selectively destroy EGFR-positive A431 cells in the presence of EGFR-negative cells in a mixed tumor model [7], while adenoviral infection with Tra-IR700 destroyed only HER2-expressing cancer cells with minimal cytotoxicity to non-infected cells [8].